1
|
Arikawa AY, Kraft D, Harris M, Perez D, Bednarzyk M, Ross JM. The relationship between diet, exercise, and inflammation in college students: A cross-sectional study. Nutr Health 2023:2601060231151263. [PMID: 36650916 DOI: 10.1177/02601060231151263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Background: Important changes in lifestyle habits, especially diet, typically occur during the transitional period between high school and college and some of these changes may increase the risk of inflammation. Aim: The purpose of this study was to investigate the relationship between lifestyle factors and inflammation in college students. Methods: Students enrolled in a southeastern university participated in this cross-sectional study. Participants completed online questionnaires for assessment of demographics, supplement and dietary intake, sleep quality, and perceived stress. Body composition was measured during a clinic visit via air displacement plethysmography and blood and urine were collected for measurement of C-reactive protein (CRP) and cortisol, respectively. Analysis of variance was used to examine associations between tertiles of CRP levels and lifestyle variables and a linear regression model was fit to investigate whether there were any significant predictors of CRP levels. Results: Analysis included data for 83 participants for whom serum CRP levels and diet intake were available. Approximately 68% of the participants were female; mean age and body mass index (BMI) were 24 years and 23.4 kg/m2, respectively. Alcohol intake was significantly associated with increasing CRP levels (P = 0.017). No other dietary variables or lifestyle characteristics such as sleep quality, perceived stress, or BMI were associated with tertiles of CRP. The best model to predict CRP levels included urinary cortisol, aerobic exercise duration, alcohol, and vitamin E intake (adjusted R2=0.27). Conclusion: Alcohol and vitamin E intake were found to be associated with increased CRP levels.
Collapse
Affiliation(s)
- Andrea Y Arikawa
- Department of Nutrition and Dietetics, 4127University of North Florida, Jacksonville, FL, USA
| | - Diane Kraft
- Department of Nutrition and Dietetics, 4127University of North Florida, Jacksonville, FL, USA
| | - Michel Harris
- Department of Nutrition and Dietetics, 4127University of North Florida, Jacksonville, FL, USA
| | - Doreen Perez
- Student Health Services, 4127University of North Florida, Jacksonville, FL, USA
| | - Michele Bednarzyk
- School of Nursing, 4127University of North Florida, Jacksonville, FL, USA
| | - Jenifer M Ross
- Department of Nutrition and Dietetics, 4127University of North Florida, Jacksonville, FL, USA
| |
Collapse
|
2
|
Haynes JM, Willis-Moore ME, Perez D, Cousins DJ, Odum AL. Temporal expectations in delay of gratification. J Exp Anal Behav 2023; 119:59-80. [PMID: 36477783 DOI: 10.1002/jeab.814] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Revised: 11/16/2022] [Accepted: 11/19/2022] [Indexed: 12/12/2022]
Abstract
We examined how temporal expectations influence preference reversals in a delay of gratification task for rats based on a hypothesis of Rachlin (2000), who suggested that preference for a larger-later reward may shift in favor of a smaller-immediate reward as a result of changes in when that larger reward is expected. To explore Rachlin's hypothesis, we preexposed two groups of rats to the delays associated with a larger-later reinforcer from a delay of gratification task. One group experienced the delays as a function of their choices in an intertemporal choice task and the other group experienced delays yoked from the first group (independent of their behavior) in an exposure training procedure. In addition, we included a third group of rats that were not exposed to delays during preexposure training as a comparison to the other two groups. Overall, the two groups of rats that experienced delays during preexposure training tended to make fewer defection responses than the comparison group during the delay of gratification task. Consistent with Rachlin's hypothesis, our results suggest that temporal learning may influence preference reversals in a delay of gratification task, providing a number of future directions for research in this area.
Collapse
Affiliation(s)
| | | | - D Perez
- Department of Psychology, Utah State University
| | | | - Amy L Odum
- Department of Psychology, Utah State University
| |
Collapse
|
3
|
Arikawa AY, Snyder J, Ross JM, Harris M, Perez D, Bednarzyk M. Dietary Supplement Intake is Associated with Healthier Lifestyle Behaviors in College Students Attending a Regional University in the Southeast: A Cross-Sectional Study. J Diet Suppl 2022; 20:870-884. [PMID: 36255153 DOI: 10.1080/19390211.2022.2134532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
The relationship between intake of dietary supplements and biomarkers such as insulin and insulin-like growth factor has not been well explored. The primary aim of this cross-sectional study was to investigate the associations between supplement intake and biological and lifestyle factors. We hypothesized that dietary supplement intake was associated with healthier lifestyle behaviors. College students attending a Southeast university were recruited between January 2018 and April 2019. Blood samples were collected to measure insulin, insulin-like growth factor 1 (IGF-1) and alanine aminotransferase (ALT). Statistical tests employed were linear regression and analysis of variance. Ninety-eight participants completed the study and 91% reported taking at least one supplement, while 5.1% reported taking 9+ supplements once per week. There were no differences in levels of insulin, IGF-1 and ALT by levels of dietary supplement intake. Although there were no differences in HEI-2015 score among the groups, those who consumed five or more supplements met a higher percentage of the recommended intake for fruits, performed aerobic exercise for longer duration, and had lower body fat percentage compared to participants who consumed two or less supplements at least once per week. These findings are consistent with previous studies and suggest that dietary supplement intake is highly prevalent in college students, and it may be related to healthy lifestyle behaviors. Future studies should employ mixed methodology to examine reasons by which college students consume dietary supplements and to assess perceived and direct health benefits associated with consumption.
Collapse
Affiliation(s)
- Andrea Y Arikawa
- Department of Nutrition and Dietetics, University of North Florida, Jacksonville, Florida, USA
| | - Jill Snyder
- Department of Nutrition and Dietetics, University of North Florida, Jacksonville, Florida, USA
| | - Jenifer M Ross
- Department of Nutrition and Dietetics, University of North Florida, Jacksonville, Florida, USA
| | - Michel Harris
- Department of Nutrition and Dietetics, University of North Florida, Jacksonville, Florida, USA
| | - Doreen Perez
- Student Health Services, University of North Florida, Jacksonville, Florida, USA
| | - Michele Bednarzyk
- School of Nursing, University of North Florida, Jacksonville, Florida, USA
| |
Collapse
|
4
|
Galena AE, Chai J, Zhang J, Bednarzyk M, Perez D, Ochrietor JD, Jahan-Mihan A, Arikawa AY. The effects of fermented vegetable consumption on the composition of the intestinal microbiota and levels of inflammatory markers in women: A pilot and feasibility study. PLoS One 2022; 17:e0275275. [PMID: 36201455 PMCID: PMC9536613 DOI: 10.1371/journal.pone.0275275] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2021] [Accepted: 08/02/2022] [Indexed: 11/18/2022] Open
Abstract
The primary objective of this pilot study was to investigate the feasibility of regular consumption of fermented vegetables for six weeks on markers of inflammation and the composition of the gut microflora in women (clinical trials ID: NTC03407794). Thirty-one women were randomized into one of three groups: 100 g/day of fermented vegetables (group A), 100 g/day pickled vegetables (group B), or no vegetables (group C) for six weeks. Dietary intake was assessed by a food frequency questionnaire and blood and stool samples were provided before and after the intervention for measurement of C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), and lipopolysaccharide binding protein (LBP). Next-generation sequencing of the V4 region of the 16S rRNA gene was performed on the Illumina MiSeq platform. Participants' ages ranged between 18 and 69 years. Both groups A and B had a mean daily consumption of 91g of vegetables for 32 and 36 days, respectively. Serum CRP ranged between 0.9 and 265 ng/mL (SD = 92.4) at baseline, while TNF-α and LBP concentrations ranged between 0 and 9 pg/mL (SD = 2.3), and 7 and 29 μg/mL (SD = 4.4), respectively. There were no significant changes in levels of inflammatory markers among groups. At timepoint 2, group A showed an increase in Faecalibacterium prausnitzii (P = 0.022), a decrease in Ruminococcus torques (P<0.05), and a trend towards greater alpha diversity measured by the Shannon index (P = 0.074). The findings indicate that consumption of ~100 g/day of fermented vegetables for six weeks is feasible and may result in beneficial changes in the composition of the gut microbiota. Future trials should determine whether consumption of fermented vegetables is an effective strategy against gut dysbiosis.
Collapse
Affiliation(s)
- Amy E. Galena
- Department of Nutrition and Dietetics, University of North Florida, Jacksonville, FL, United States of America
| | - Jianmin Chai
- Division of Agriculture, Department of Animal Science, University of Arkansas, Fayetteville, AR, United States of America
| | - Jiangchao Zhang
- Division of Agriculture, Department of Animal Science, University of Arkansas, Fayetteville, AR, United States of America
| | - Michele Bednarzyk
- School of Nursing, University of North Florida, Jacksonville, FL, United States of America
| | - Doreen Perez
- School of Nursing, University of North Florida, Jacksonville, FL, United States of America
| | - Judith D. Ochrietor
- Department of Biology, University of North Florida, Jacksonville, FL, United States of America
| | - Alireza Jahan-Mihan
- Department of Nutrition and Dietetics, University of North Florida, Jacksonville, FL, United States of America
| | - Andrea Y. Arikawa
- Department of Nutrition and Dietetics, University of North Florida, Jacksonville, FL, United States of America
- * E-mail:
| |
Collapse
|
5
|
Perez D, Harte F, Lopez-Pedemonte T. Ionic strength and buffering capacity of emulsifying salts determine denaturation and gelation temperatures of whey proteins. J Dairy Sci 2022; 105:7230-7241. [PMID: 35879172 DOI: 10.3168/jds.2021-21738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2021] [Accepted: 04/24/2022] [Indexed: 11/19/2022]
Abstract
Ionic conditions affect the denaturation and gelling of whey proteins, affecting the physical properties of foods in which proteins are used as ingredients. We comprehensively investigated the effect of the presence of commonly used emulsifying salts on the denaturation and gelling properties of concentrated solutions of β-lactoglobulin (β-LG) and whey protein isolate (WPI). The denaturation temperature in water was 73.5°C [coefficient of variation (CV) 0.49%], 71.8°C (CV 0.38%), and 69.9°C (CV 0.41%) for β-LG (14% wt/wt), β-LG (30% wt/wt), and WPI (30% wt/wt), respectively. Increasing the concentration of salts, except for sodium hexametaphosphate, resulted in a linear increase in the denaturation temperature of WPI (kosmotropic behavior) and an acceleration in its gelling rate. Sodium chloride and tartrate salts exhibited the strongest effect in protecting WPI against thermal denaturation. Despite the constant initial pH of all solutions, salts having buffering capacity (e.g., phosphate and citrate salts) prevented a decrease in pH as the temperature increased above 70°C, resulting in a decline in denaturation temperature at low salt concentrations (≤0.2 mol/g). When pH was kept constant at denaturation temperature, all salts except sodium hexametaphosphate, which exhibited chaotropic behavior, exhibited similar effects on denaturation temperature. At low salt concentration, gelation was the controlling step, occurring up to 10°C above denaturation temperature. At high salt concentration (>3% wt/wt), thermal denaturation was the controlling step, with gelation occurring immediately after. These results indicate that the ionic and buffering properties of salts added to milk will determine the native versus denatured state and gelation of whey proteins in systems subjected to high temperature, short time processing (72°C for 15 s).
Collapse
Affiliation(s)
- D Perez
- Unidad de Ciencia y Tecnología de Lácteos, Instituto Tecnológico Suroeste, Universidad Tecnológica del Uruguay, La Paz, Colonia Piamontesa, Colonia, 70200, Uruguay.
| | - F Harte
- Department of Food Science, Pennsylvania State University, University Park 16802
| | - T Lopez-Pedemonte
- Unidad de Ciencia y Tecnología de Lácteos, Instituto Tecnológico Suroeste, Universidad Tecnológica del Uruguay, La Paz, Colonia Piamontesa, Colonia, 70200, Uruguay
| |
Collapse
|
6
|
Parmenter JG, Galliher RV, Wong E, Perez D. An intersectional approach to understanding LGBTQ+ people of color's access to LGBTQ+ community resilience. J Couns Psychol 2021; 68:629-641. [PMID: 34398620 DOI: 10.1037/cou0000578] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Resiliency research suggests that connection to LGBTQ + communities helps mitigate the negative impacts of oppression (i.e., community resilience). However, due to various interlocking systems of oppression, those with multiple marginalized identities [i.e., LGBTQ + people of color (POC)] may not have equal access to LGBTQ + community resilience resources. Despite the growing body of literature, little research has explored LGBTQ + POC's experiences with the LGBTQ + community from an intersectional framework to critique systems of oppression and provide implications for social justice. Fourteen LGBTQ + POC participated in semistructured interviews to explore their experiences with protective factors of the LGBTQ + community and the barriers they face in accessing community resilience. Findings supported three broad categories with subthemes: (1) LGBTQ + Community Resilience Resources (i.e., Shared Narratives and Feeling Seen and Social Justice and Liberation), (2) Inequity to Accessing LGBTQ + Community Resilience (i.e., Alienation and Exclusion, Disempowerment and Exploitation, and Invisibility), and (3) Making Space. Utilizing our intersectional framework, we provide implications for social justice advocacy as well as clinical and educational implications for counseling psychologists and community organizations. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
Collapse
|
7
|
Schreurs RRCE, Sagebiel AF, Steinert FL, Highton AJ, Klarenbeek PL, Drewniak A, Bakx R, The SML, Ribeiro CMS, Perez D, Reinshagen K, Geijtenbeek TBH, van Goudoever JB, Bunders MJ. Intestinal CD8 + T cell responses are abundantly induced early in human development but show impaired cytotoxic effector capacities. Mucosal Immunol 2021; 14:605-614. [PMID: 33772147 PMCID: PMC8075922 DOI: 10.1038/s41385-021-00382-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2020] [Revised: 09/30/2020] [Accepted: 11/02/2020] [Indexed: 02/04/2023]
Abstract
Gastrointestinal viral infections are a major global cause of disease and mortality in infants. Cytotoxic CD8+ T cells are critical to achieve viral control. However, studies investigating the development of CD8+ T cell immunity in human tissues early in life are lacking. Here, we investigated the maturation of the CD8+ T cell compartment in human fetal, infant and adult intestinal tissues. CD8+ T cells exhibiting a memory phenotype were already detected in fetal intestines and increased after birth. Infant intestines preferentially harbored effector CCR7-CD45RA-CD127-KLRG1+/- CD8+ T cells compared to tissue-resident memory CD69+CD103+CD8+ T cells detected in adults. Functional cytotoxic capacity, including cytokine and granzyme B production of infant intestinal effector CD8+ T cells was, however, markedly reduced compared to adult intestinal CD8+ T cells. This was in line with the high expression of the inhibitory molecule PD-1 by infant intestinal effector CD8+ T cells. Taken together, we demonstrate that intestinal CD8+ T cell responses are induced early in human development, however exhibit a reduced functionality. The impaired CD8+ T cell functionality early in life contributes to tolerance during foreign antigen exposure after birth, however functions as an immune correlate for the increased susceptibility to gastrointestinal viral infections in infancy.
Collapse
Affiliation(s)
- R. R. C. E. Schreurs
- grid.7177.60000000084992262Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center (AUMC), University of Amsterdam (UvA), Amsterdam, The Netherlands ,grid.7177.60000000084992262Department of Pediatrics, Emma Children’s Hospital, AUMC, UvA, Amsterdam, The Netherlands
| | - A. F. Sagebiel
- grid.418481.00000 0001 0665 103XHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
| | - F. L. Steinert
- grid.418481.00000 0001 0665 103XHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
| | - A. J. Highton
- grid.418481.00000 0001 0665 103XHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
| | - P. L. Klarenbeek
- grid.7177.60000000084992262Department of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, AUMC, UvA, Amsterdam, The Netherlands ,grid.16872.3a0000 0004 0435 165XAmsterdam Rheumatology & Immunology Center, AUMC, UvA, Amsterdam, The Netherlands
| | - A. Drewniak
- grid.7177.60000000084992262Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center (AUMC), University of Amsterdam (UvA), Amsterdam, The Netherlands ,grid.467476.00000 0004 0483 1848Kiadis Pharma B.V., Amsterdam, The Netherlands
| | - R. Bakx
- Department of Pediatric Surgery, Pediatric Surgery Center of Amsterdam, AUMC, Amsterdam, The Netherlands
| | - S. M. L. The
- grid.7177.60000000084992262Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center (AUMC), University of Amsterdam (UvA), Amsterdam, The Netherlands ,Department of Pediatric Surgery, Pediatric Surgery Center of Amsterdam, AUMC, Amsterdam, The Netherlands
| | - C. M. S. Ribeiro
- grid.7177.60000000084992262Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center (AUMC), University of Amsterdam (UvA), Amsterdam, The Netherlands
| | - D. Perez
- grid.13648.380000 0001 2180 3484Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - K. Reinshagen
- grid.13648.380000 0001 2180 3484Department of Pediatric Surgery, UKE, Hamburg, Germany
| | - T. B. H. Geijtenbeek
- grid.7177.60000000084992262Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center (AUMC), University of Amsterdam (UvA), Amsterdam, The Netherlands
| | - J. B. van Goudoever
- grid.7177.60000000084992262Department of Pediatrics, Emma Children’s Hospital, AUMC, UvA, Amsterdam, The Netherlands ,grid.12380.380000 0004 1754 9227Department of Pediatrics, Emma Children’s Hospital, AUMC, Vrije Universiteit, Amsterdam, The Netherlands
| | - M. J. Bunders
- grid.7177.60000000084992262Department of Experimental Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Center (AUMC), University of Amsterdam (UvA), Amsterdam, The Netherlands ,grid.7177.60000000084992262Department of Pediatrics, Emma Children’s Hospital, AUMC, UvA, Amsterdam, The Netherlands ,grid.418481.00000 0001 0665 103XHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany
| |
Collapse
|
8
|
Affiliation(s)
- N.E. Caporale
- Seine, Hospital Español Departamento de Parasitologia Facultad de Medicina
| | - L. Calegari
- Universidad de la Republica Montevideo, Uruguay
| | - D. Perez
- Seine, Hospital Español Departamento de Parasitologia Facultad de Medicina
| | - E. Gezuele
- Universidad de la Republica Montevideo, Uruguay
| |
Collapse
|
9
|
Affiliation(s)
- N. Caporale
- Servicio Integral de Nefrologia (SE.I.NE) Hospital Espanol, P.O. Box 1138 11000 Montevideo, Uruguay
| | - D. Perez
- Servicio Integral de Nefrologia (SE.I.NE) Hospital Espanol, P.O. Box 1138 11000 Montevideo, Uruguay
| | - S. Alegre
- Servicio Integral de Nefrologia (SE.I.NE) Hospital Espanol, P.O. Box 1138 11000 Montevideo, Uruguay
| |
Collapse
|
10
|
Sturmheit T, Konczalla L, Temovski TS, Günther A, Brauneck F, Li J, Perez D, Jücker M, Thastrup J, Fiedler W, Wellbrock J, Kupper J, Block A. Pre-therapeutic Evaluation of Patient-Specific Responses to Immune-Checkpoint Inhibition in Colorectal Cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz450.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
11
|
Menacho Medina KD, Ramirez S, Katekaru D, Dragonetti L, Perez D, Illatopa V, Rodriguez B, Bansal R, Rodriguez I, Jacob R, Ntusi N, Herrey A, Westwood M, Walker M, Mooon J. 28Impact of non-invasive rapid cardiac magnetic resonance for the assessment of cardiomyopathies in developing countries. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cardiovascular mortality is higher in developing countries. Part of that is suboptimal testing. Cardiac magnetic resonance (CMR) is the gold standard for measuring structure, function of the heart and adds incremental value by imaging scarring and to assess iron level. Despite the existence of MRI units, CMR is identified as a complex test, with poor training and availability in developing countries.
Purpose
To assess the potential impact of a faster CMR protocol at a multicentre level in developing countries; implementing it with an education program, for the assessment cardiomyopathies.
Methods
An international partnership. A rapid CMR protocol for the evaluation of cardiac volumes, function and tissue characterization (Cardiac Iron T2* and LGE for scar) Figure 1a. We deployed the protocol as a multicentre study: Argentina, Peru, India and South Africa accompanied by a program of education. Pre-scan clinical information, scanning data: complications, image quality and post-scan follow-up of participants for the assessment on impact, between 3 to 24 months.
Results
510 scans (4 countries, 6 cities, 12 centres) were performed with the rapid CMR protocol. Contrast studies in 378 (74%). There were no scan-related complications. Quality of the studies was maintained in a high level as an average of 89%. 97% of studies responded referral's question. All patients with contrast CMR scan have had at least one 2D echocardiogram before CMR. Average scan duration was 21±6 mins for contrast studies and 12±3 for non-contrast T2* protocol. The most common underlying diagnoses were non-ischaemic cardiomyopathy in 73% of participants (including cardiac iron level assessment in 26%, HCM in 17%, DCM in 15%), 27% for ischaemic cardiomyopathy and 15% for other pathologies. 4 of the 12 participant centres started to incorporate CMR for the first time. Findings impacted management in 60% of patients, including new diagnosis in 21% of participants. See table 1, figure 1b. For just cardiac iron assessment: 1/3 of participants had iron deposited in the heart with 14% of patients in severe levels.
Conclusions
CMR can be delivered faster and easier. When this abbreviated protocol is enabled with education, it can be implemented in developing countries with existing technology. This protocol shows high quality exam, with an important impact on patient's management.
Characteristics and impact on management Contrast studies Non-contrast studies All patients (%) 378 (74) 132 (36) Age, mean (range) years 54 (16–93) 24 (13–41) Male (%) 151 (39) 64 (48) Pre-echocardiography exam (%) 370 (98) 42 (32) Scanning duration mean (SD) 21 (6) 12 (3) Good quality exam (%) 329 (87) 120 (91) Impact on management Total All patients (%) 510 (100) Completely new diagnosis (%) 105 (21) Change/Addition of Medication (%) 128 (25) Intervention/ Surgery (%) 31 (6) Invasive angiography/biopsy (%) 25 (5) Hospital discharge/admission (%) 15 (3) TOTAL 306 (60%) SD: Standard Deviation.
Acknowledgement/Funding
Global Engagement UCL, UK Foreign & Commonwealth Office and The Peruvian Scientific, Technological Development and Technological Innovation (FONDECYT)
Collapse
Affiliation(s)
| | - S Ramirez
- International Clinic, Lima – Peru, Cardiac Imaging Department, Lima, Peru
| | - D Katekaru
- Military Hospital, Cardiac Imaging Department, Lima, Peru
| | - L Dragonetti
- High Technology Medical Institute - IMAT, Radiology Department, Buenos Aires, Argentina
| | - D Perez
- Italian Hospital of Buenos Aires, Buenos Aires, Argentina
| | - V Illatopa
- National Cardiovascular Institute - INCOR, Lima, Peru
| | - B Rodriguez
- Edgardo Rebagliati Hospital, MRI and CT Department, Lima, Peru
| | - R Bansal
- Bhawani Singh Marg Hospital and OK Diagnostic Centre, Jaipur, India
| | | | - R Jacob
- Lancaster General Health Hospital, Lancaster, United States of America
| | - N Ntusi
- University of Cape Town, Cape Town, South Africa
| | - A Herrey
- St Bartholomew's Hospital, Barts Hear Centre, London, United Kingdom
| | - M Westwood
- St Bartholomew's Hospital, Barts Hear Centre, London, United Kingdom
| | - M Walker
- University College London, London, United Kingdom
| | - J Mooon
- St Bartholomew's Hospital, Barts Hear Centre, London, United Kingdom
| |
Collapse
|
12
|
Pedrinaci IZ, Perez D, Rivas-Ruiz F, Sala M, Padilla-Ruiz M, Alcaide-Garcia J, Perez-Ruiz E, Villatoro R, Navarro V, Redondo M. Influence of first treatment delay on survival among breast cancer subtypes. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz240.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
13
|
Mishall PL, Marsh AN, Perez D, Quezada XH, Stahl MC, Weinstock RE, Downie SA. Novel, bilateral, two-bellied muscles span the extensor forearm, thenar eminence to insert on the proximal phalanx of the thumb: clinical and embryological significance. Folia Morphol (Warsz) 2019; 79:182-187. [PMID: 31169299 DOI: 10.5603/fm.a2019.0067] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2019] [Revised: 05/28/2019] [Accepted: 05/29/2019] [Indexed: 11/25/2022]
Abstract
Muscle and tendon variations in the forearm, wrist and hand are commonly reported in the anatomical and surgical literature. They are frequently the source of inflammatory conditions such as de Quervain's tenosynovitis or carpal tunnel syndrome. During academic dissection, a cadaver presented with bilateral, additional muscles running parallel to the abductor pollicis longus muscles (APL) in the extensor compartment of the forearm. Both additional muscles had two bellies, one proximal and one distal, with an intervening tendon. The proximal bellies were separate and distinct from the adjacent APLs. The tendons traversed the first dorsal compartments with the tendons of the APLs and the extensor pollicis brevis muscles (EPB). The distal bellies lay adjacent to the abductor pollicis brevis (APB) muscles in the thenar compartments, and inserted onto the volar base of the proximal phalanges of the thumbs. Following a thorough search of the literature, we determined that these additional muscles constitute a previously unreported variation. This report details the variation, compares it with other reported variations, presents the related embryology, and reviews the significance of this variation as it relates to inflammatory conditions and surgical procedures.
Collapse
Affiliation(s)
- P L Mishall
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, 1300 Morris Park Ave, 10465 Bronx, New York, United States. .,Department of Ophthalmology and Visual Scienees, Albert Einstein College of Medicine, Bronx, New York, United States.
| | - A N Marsh
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, 1300 Morris Park Ave, 10465 Bronx, New York, United States
| | - D Perez
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, 1300 Morris Park Ave, 10465 Bronx, New York, United States
| | - X H Quezada
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, 1300 Morris Park Ave, 10465 Bronx, New York, United States
| | - M C Stahl
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, 1300 Morris Park Ave, 10465 Bronx, New York, United States
| | - R E Weinstock
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, 1300 Morris Park Ave, 10465 Bronx, New York, United States
| | - S A Downie
- Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, Bronx, 1300 Morris Park Ave, 10465 Bronx, New York, United States.,Department of Physical Medicine and Rehabilitation, Bronx, New York, United States
| |
Collapse
|
14
|
Salazar-Vargas A, Soca-Chafre G, Lome-Maldonado C, Moreno L, Perez D, Rivas-Vera S, Ramirez-Ibarguen A. PREVALENCE OF EPSTEIN BARR VIRUS IN FOLICULAR LYMPHOMA AND PROGNOSTIC VALUE OF FOXP1 AND P53 BIOMARKERS IN A MEXICAN POPULATION. Hematol Oncol 2019. [DOI: 10.1002/hon.3_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
| | - G. Soca-Chafre
- Personalized Medicine Laboratory; National Cancer Institute of Mexico; Mexico City Mexico
| | - C. Lome-Maldonado
- Hemato-pathology; National Cancer Institute of Mexico; Mexico City Mexico
| | - L. Moreno
- Hemato-pathology; National Cancer Institute of Mexico; Mexico City Mexico
| | - D. Perez
- Hemato-pathology; National Cancer Institute of Mexico; Mexico City Mexico
| | - S. Rivas-Vera
- Hematology; National Cancer Institute of Mexico; Mexico City Mexico
| | | |
Collapse
|
15
|
Uzunoglu FG, Welte MN, Gavazzi F, Maggino L, Perinel J, Salvia R, Janot M, Reeh M, Perez D, Montorsi M, Zerbi A, Adham M, Uhl W, Bassi C, Izbicki JR, Malleo G, Bockhorn M. Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort. Eur J Surg Oncol 2018; 45:793-799. [PMID: 30585172 DOI: 10.1016/j.ejso.2018.12.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2018] [Revised: 12/06/2018] [Accepted: 12/18/2018] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND The MDACC group recommends to extend the current borderline classification for pancreatic cancer into three groups: type A patients with resectable/borderline tumor anatomy, type B with resectable/borderline resectable tumor anatomy and clinical findings suspicious for extrapancreatic disease and type C with borderline resectable and marginal performance status/severe pre-existing comorbidity profile or age>80. This study intents to evaluate the proposed borderline classification system in a multicenter patient cohort without neoadjuvant treatment. METHODS Evaluation was based on a multicenter database of pancreatic cancer patients undergoing surgery from 2005 to 2016 (n = 1020). Complications were classified based on the Clavien-Dindo classification. χ2-test, Kaplan-Meier estimator and Cox regression hazard model were used for statistical analysis. RESULTS Most patients (55.1%) were assigned as type A patients, followed by type C (35.8%) and type B patients (9.1%). Neither the complication rate, nor the mortality rate revealed a correlation to any subgroup. Type B patients had a significant worse progression free (p < 0.001) and overall survival (p = 0.005). Type B classification was identified as an independent prognostic marker for progression free survival (p = 0.005, HR 1.47). CONCLUSION The evaluation of the proposed classification in a cohort without neoadjuvant treatment did not justify an additional medical borderline subgroup. A new subgroup based on prognostic borderline patients might be the main target group for neoadjuvant protocols in future.
Collapse
Affiliation(s)
- F G Uzunoglu
- Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - M-N Welte
- Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - F Gavazzi
- Department of General Surgery, Humanitas Research Hosptital and University, Istituto Clinico Humanitas IRCCS, Milan, Italy
| | - L Maggino
- Department of Surgery and Oncology, Unit of General and Pancreatic Surgery, The Pancreas Institute, G.B. Rossi Hospital, University of Verona Hospital Trust, Verona, Italy
| | - J Perinel
- Hospices Civils de Lyon & Lyon Sud Faculty of Medicine, UCBL1, E. Herriot Hospital, Department of Digestive Surgery, Lyon, France
| | - R Salvia
- Department of Surgery and Oncology, Unit of General and Pancreatic Surgery, The Pancreas Institute, G.B. Rossi Hospital, University of Verona Hospital Trust, Verona, Italy
| | - M Janot
- Department of Surgery, St. Josef-Hospital Bochum, Hospital of the Ruhr- University, Bochum, Germany
| | - M Reeh
- Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - D Perez
- Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - M Montorsi
- Department of General Surgery, Humanitas Research Hosptital and University, Istituto Clinico Humanitas IRCCS, Milan, Italy
| | - A Zerbi
- Department of General Surgery, Humanitas Research Hosptital and University, Istituto Clinico Humanitas IRCCS, Milan, Italy
| | - M Adham
- Hospices Civils de Lyon & Lyon Sud Faculty of Medicine, UCBL1, E. Herriot Hospital, Department of Digestive Surgery, Lyon, France
| | - W Uhl
- Department of Surgery, St. Josef-Hospital Bochum, Hospital of the Ruhr- University, Bochum, Germany
| | - C Bassi
- Department of Surgery and Oncology, Unit of General and Pancreatic Surgery, The Pancreas Institute, G.B. Rossi Hospital, University of Verona Hospital Trust, Verona, Italy
| | - J R Izbicki
- Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - G Malleo
- Department of Surgery and Oncology, Unit of General and Pancreatic Surgery, The Pancreas Institute, G.B. Rossi Hospital, University of Verona Hospital Trust, Verona, Italy
| | - M Bockhorn
- Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
| |
Collapse
|
16
|
Kennedy A, Valdez R, Westfield C, Bolen J, Kinnett K, Perez D, Furlong P. REGISTRIES AND CARE OF NEUROMUSCULAR DISORDERS. Neuromuscul Disord 2018. [DOI: 10.1016/j.nmd.2018.06.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
17
|
Shovman O, Gilburd B, Watad A, Amital H, Langevitz P, Bragazzi N, Adawi M, Perez D, Bornstein G, Grossman C, Lidar M, Blank M, Azuri J, Biln N, Marotta A, Shoenfeld Y. The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis. Best Pract Res Clin Rheumatol 2018; 32:610-617. [DOI: 10.1016/j.berh.2019.01.010] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
18
|
Ibanez J, Martinez J, Perez D, Sanchez I, Idoate A, Berniolles J, Bartolome I, Lopez I, Ascaso Puyuelo F. Modifications in corneal biomechanics and intraocular pressure after deep sclerectomy. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.0s056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J. Ibanez
- Glaucoma; Hospital Clinico Lozano Blesa Zaragoza; Zaragoza Spain
| | - J. Martinez
- Glaucoma; Hospital Clinico Lozano Blesa Zaragoza; Zaragoza Spain
| | - D. Perez
- Glaucoma; Hospital Clinico Lozano Blesa Zaragoza; Zaragoza Spain
| | - I. Sanchez
- Glaucoma; Hospital Clinico Lozano Blesa Zaragoza; Zaragoza Spain
| | - A. Idoate
- Glaucoma; Hospital Clinico Lozano Blesa Zaragoza; Zaragoza Spain
| | - J. Berniolles
- Glaucoma; Hospital Clinico Lozano Blesa Zaragoza; Zaragoza Spain
| | - I. Bartolome
- Glaucoma; Hospital Clinico Lozano Blesa Zaragoza; Zaragoza Spain
| | - I. Lopez
- Glaucoma; Hospital Clinico Lozano Blesa Zaragoza; Zaragoza Spain
| | | |
Collapse
|
19
|
Matos L, Muñoz M, Molina J, Rodríguez F, Perez D, Lopez A, Ferrer O, Hermosilla C, Taubert A, Ruiz A. Protective immune responses during prepatency in goat kids experimentally infected with Eimeria ninakohlyakimovae. Vet Parasitol 2017; 242:1-9. [DOI: 10.1016/j.vetpar.2017.04.016] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2016] [Revised: 03/10/2017] [Accepted: 04/12/2017] [Indexed: 10/19/2022]
|
20
|
Nentwich M, Menzel K, Reeh M, Uzunoglu F, Ghadban T, Bachmann K, Schrader J, Bockhorn M, Izbicki J, Perez D. Blood fibrinogen levels discriminate low- and high-risk intraductal papillary mucinous neoplasms (IPMNs). Eur J Surg Oncol 2017; 43:758-762. [DOI: 10.1016/j.ejso.2016.12.013] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2016] [Revised: 12/05/2016] [Accepted: 12/16/2016] [Indexed: 01/26/2023] Open
|
21
|
Schrader J, Henes F, Perez D, Burdak-Rothkamm S, Stein A, Izbicki J, Lohse A. Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation. Ann Oncol 2017; 28:904-905. [DOI: 10.1093/annonc/mdx007] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Indexed: 01/10/2023] Open
|
22
|
Pedrinaci IZ, Romero A, Louro J, Banqué M, Vernet M, Serrano L, Funez R, Medina F, Perez D, Rueda A, Sala M, Redondo M. Survival impact of adjuvant chemotherapy in screening breast cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw364.63] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
23
|
Alcaide-Garcia J, Pereda T, Perez-Ruiz E, Rivas F, Pedrinaci IZ, Villatoro R, Perez D, Rueda A. Concordance of KRAS, NRAS and BRAF status between primary colorectal tumors and paired metastasis (mts). Ann Oncol 2016. [DOI: 10.1093/annonc/mdw370.83] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Vendramini JMB, Leite de Oliveira F, Sanchez JMD, Yarborough J, Perez D, Ralston J, Cooke RF. 0659 Monensin effects on early-weaned beef calves grazing annual ryegrass pastures. J Anim Sci 2016. [DOI: 10.2527/jam2016-0659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
25
|
Idoate A, Ascaso F, Perez D, Remón L, Perez I, Almenara C, Esteban O, Martinez M, Sanchéz J, Berniolles J, Bartolomé I. Rupture of Descemet's membrane associated with forceps delivery. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0608] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
26
|
Perez D, Huet C, Chea M, Jenny C, Clairand I. Evaluation of the Tomotherapy treatment planning system for out-of-field doses calculation. Phys Med 2015. [DOI: 10.1016/j.ejmp.2015.10.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
27
|
Eterovic V, Carrasco M, Perez D, Ebrahim H, Ferchmin P, El Sayed K. Cembranoids structure–activity relationship for protection against diisopropylfluorophosphate damage. Biochem Pharmacol 2015. [DOI: 10.1016/j.bcp.2015.08.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
28
|
Garcia-Blanca A, Aranda A, Blanca-Lopez N, Perez D, Gomez F, Mayorga C, Torres MJ, Diaz-Perales A, Perkins JR, Villalba M, Blanca M, Canto G. Influence of age on IgE response in peanut-allergic children and adolescents from the Mediterranean area. Pediatr Allergy Immunol 2015; 26:497-502. [PMID: 26046378 DOI: 10.1111/pai.12418] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/28/2015] [Indexed: 11/30/2022]
Abstract
BACKGROUND Peanut allergens are common triggers of food allergy. Analyses of sensitization patterns, relationships with other allergens, clinical symptoms, and variation with age are needed. We studied sensitization to Ara h 2, Ara h 9, and Pru p 3 in a peanut allergic children/adolescents and the relationship with peach and pollen. METHODS Peanut allergic patients aged between 1 and 20 years old were classified into two groups: A) allergic to peanut only and B) allergic to peach and peanut. The IgE response was measured to Ara h 2, Ara h 9, and Pru p 3. RESULTS Of 964 subjects evaluated, 28% were allergic to peanut. From this group, 68% were also sensitized to pollen. Urticaria was the most frequent entity followed by anaphylaxis and OAS. Fifty-eight percent had Ara h 2- and/or Ara h 9-specific IgE. More than half reported symptoms with peanut alone (Group A) and 35% to peanut and peach (Group B). We observed significant differences in sex, age, onset of symptoms, and sensitization to Artemisia between groups. IgE response to Ara h 2 was more frequent in Group A, and Ara h 9 and Pru p 3 in Group B. We observed a decrease in sensitization to Ara h 2 and an increase to Ara h 9 and Pru p 3 with increasing age. CONCLUSION Peanut allergy is frequent in subjects with allergy to plant foods, with Ara h 2 and Ara h 9 being two important allergens. In younger patients, Ara h 2 predominates over Ara h 9. The reverse was observed in older patients.
Collapse
Affiliation(s)
| | - A Aranda
- Research Laboratory, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain
| | | | - D Perez
- Allergy Service, Infanta Leonor Hospital, Madrid, Spain
| | - F Gomez
- Allergy UGC, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain
| | - C Mayorga
- Research Laboratory, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain
| | - M J Torres
- Allergy UGC, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain
| | | | - J R Perkins
- Research Laboratory, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain
| | - M Villalba
- Biochemistry and Molecular Biology Department, University Complutense Madrid, Madrid, Spain
| | - M Blanca
- Allergy UGC, IBIMA, Regional University Hospital of Malaga, UMA, Malaga, Spain
| | - G Canto
- Allergy Service, Infanta Leonor Hospital, Madrid, Spain
| |
Collapse
|
29
|
van Hazel G, Heinemann V, Sharma N, Findlay M, Ricke J, Peeters M, Perez D, Robinson B, Strickland A, Ferguson T, Rodrigez J, Kroening H, Wolf I, Ganju V, Walpole E, Boucher E, Tichler T, Gebski V, Van Buskirk M, Gibbs P. O-019 SIRFLOX: Randomized trial comparing first-line mFOLFOX6 ± bevacizumab versus mFOLFOX6 + selective internal radiation therapy (SIRT) ± bevacizumab in patients with metastatic colorectal cancer (mCRC) – analysis by presence or absence of extra-hepatic metastases and bevacizumab treatment. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv235.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
30
|
Perez D, Sharples KJ, Broom R, Jeffery M, Proctor J, Hinder V, Pollard S, Edwards J, Simpson A, Scott J, Benge S, Krissansen G, Geursen A, Palmano K, MacGibbon A, Keefe D, Findlay M. A randomised phase IIb trial to assess the efficacy of ReCharge ice cream in preventing chemotherapy-induced diarrhoea. Support Care Cancer 2015; 23:3307-15. [PMID: 26018599 DOI: 10.1007/s00520-015-2755-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2014] [Accepted: 04/27/2015] [Indexed: 01/20/2023]
Abstract
PURPOSE Chemotherapy-induced diarrhoea (CID) has a significant impact. A medicinal food product (ReCharge) containing iron-saturated lactoferrin and anhydrous milk fat reduces the detrimental effects of chemotherapy on the gut in animals. We report results of a randomised blinded placebo-controlled phase IIb trial investigating the efficacy and safety of ReCharge in preventing CID. METHODS Eligible patients were adults due to start the first cycle of a 2- or 3-week-cycle chemotherapy regimen, had an Eastern Cooperative Oncology Group (ECOG) status of 3 or less, had adequate haematological, liver and renal function and provided written informed consent. Patients (197) were randomised to ReCharge or placebo. They consumed 100-g study product for 2 weeks before and 6 weeks after starting chemotherapy, completed daily diaries for 8 weeks and attended clinic visits until 12 weeks (2-week cycles) or 14 weeks (3-week cycles). The primary outcome was days with CID. RESULTS The mean number of days with diary-recorded CID was marginally but not statistically significantly lower on ReCharge than placebo (-2.0, 95 % CI (-4.7 to 0.7), p = 0.2). The proportion reporting diarrhoea in the previous cycle at the clinic visit was 30 % lower (p = 0.012) on ReCharge. Missing diary data may have contributed to the discrepancy. No significant differences were found in quality of life or other adverse events. CONCLUSIONS We found no clear evidence that ReCharge reduced CID as measured by patient self-report diary. The converse finding of benefit as recorded at clinic visits and incomplete adherence to diary completion indicates that further research is required into methods for measuring CID.
Collapse
Affiliation(s)
- D Perez
- University of Otago Medical School, Dunedin, New Zealand. .,Department of Oncology, Dunedin Hospital, Private Bag 1921, Dunedin, 9054, New Zealand.
| | - K J Sharples
- Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.,Cancer Trials New Zealand, University of Auckland Faculty of Medical & Health Sciences, Auckland, New Zealand
| | - R Broom
- Auckland Regional Cancer & Blood Service, Auckland District Health Board, Auckland, New Zealand
| | - M Jeffery
- Medical Oncology, Canterbury District Health Board, Christchurch, New Zealand
| | - J Proctor
- Cancer Trials New Zealand, University of Auckland Faculty of Medical & Health Sciences, Auckland, New Zealand
| | - V Hinder
- Cancer Trials New Zealand, University of Auckland Faculty of Medical & Health Sciences, Auckland, New Zealand
| | - S Pollard
- Cancer Trials New Zealand, University of Auckland Faculty of Medical & Health Sciences, Auckland, New Zealand
| | - J Edwards
- Wellington Blood & Cancer Centre, Capital & Coast District Health Board, Kilbirnie, New Zealand
| | - A Simpson
- Wellington Blood & Cancer Centre, Capital & Coast District Health Board, Kilbirnie, New Zealand
| | - J Scott
- Cancer Trials New Zealand, University of Auckland Faculty of Medical & Health Sciences, Auckland, New Zealand
| | - S Benge
- Cancer Trials New Zealand, University of Auckland Faculty of Medical & Health Sciences, Auckland, New Zealand
| | - G Krissansen
- Cancer Trials New Zealand, University of Auckland Faculty of Medical & Health Sciences, Auckland, New Zealand
| | - A Geursen
- LactoPharma NZ LTD-Fonterra Co-operative Group Ltd., Hamilton, New Zealand
| | - K Palmano
- LactoPharma NZ LTD-Fonterra Co-operative Group Ltd., Hamilton, New Zealand
| | - A MacGibbon
- LactoPharma NZ LTD-Fonterra Co-operative Group Ltd., Hamilton, New Zealand
| | - D Keefe
- University of Adelaide, Adelaide, Australia
| | - M Findlay
- Cancer Trials New Zealand, University of Auckland Faculty of Medical & Health Sciences, Auckland, New Zealand
| |
Collapse
|
31
|
Bernhardt BM, Hanson R, Perez D, Ávila C, Lleó C, Stemberger JP, Carballo G, Mendoza E, Fresneda D, Chávez-Peón M. Word structures of Granada Spanish-speaking preschoolers with typical versus protracted phonological development. Int J Lang Commun Disord 2015; 50:298-311. [PMID: 25521065 DOI: 10.1111/1460-6984.12133] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2013] [Accepted: 08/24/2014] [Indexed: 06/04/2023]
Abstract
BACKGROUND Research on children's word structure development is limited. Yet, phonological intervention aims to accelerate the acquisition of both speech-sounds and word structure, such as word length, stress or shapes in CV sequences. Until normative studies and meta-analyses provide in-depth information on this topic, smaller investigations can provide initial benchmarks for clinical purposes. AIMS To provide preliminary reference data for word structure development in a variety of Spanish with highly restricted coda use: Granada Spanish (similar to many Hispano-American varieties). To be clinically applicable, such data would need to show differences by age, developmental typicality and word structure complexity. Thus, older typically developing (TD) children were expected to show higher accuracy than younger children and those with protracted phonological development (PPD). Complex or phonologically marked forms (e.g. multisyllabic words, clusters) were expected to be late developing. METHODS & PROCEDURES Participants were 59 children aged 3-5 years in Granada, Spain: 30 TD children, and 29 with PPD and no additional language impairments. Single words were digitally recorded by a native Spanish speaker using a 103-word list and transcribed by native Spanish speakers, with confirmation by a second transcriber team and acoustic analysis. The program Phon 1.5 provided quantitative data. OUTCOMES & RESULTS In accordance with expectations, the TD and older age groups had better-established word structures than the younger children and those with PPD. Complexity was also relevant: more structural mismatches occurred in multisyllabic words, initial unstressed syllables and clusters. Heterosyllabic consonant sequences were more accurate than syllable-initial sequences. The most common structural mismatch pattern overall was consonant deletion, with syllable deletion most common in 3-year-olds and children with PPD. CONCLUSIONS & IMPLICATIONS The current study provides preliminary reference data for word structure development in a Spanish variety with restricted coda use, both by age and types of word structures. Between ages 3 and 5 years, global measures (whole word match, word shape match) distinguished children with typical versus protracted phonological development. By age 4, children with typical development showed near-mastery of word structures, whereas 4- and 5-year-olds with PPD continued to show syllable deletion and cluster reduction, especially in multisyllabic words. The results underline the relevance of multisyllabic words and words with clusters in Spanish phonological assessment and the utility of word structure data for identification of protracted phonological development.
Collapse
|
32
|
Jakobi A, Bandurska-Luque A, Stützer K, Haase R, Löck S, Wack L, Mönnich D, Thorwarth D, Kovacevic M, Perez D, Lühr A, Zips D, Krause M, Baumann M, Perrin R, Richter C. PO-0898: Identification of individual NTCP benefit of dose-escalated IMPT in advanced HNC patients. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40890-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Agaimy A, Bauer S, Beham A, Bertolini J, Haller F, Koschny R, Maier J, Montemurro M, Perez D, Schaefer IM, Schildhaus HU, Wurst C, Cameron S. Gastrointestinale Stromatumoren (GIST) – Neues zu Pathologie, Chirurgie und medikamentöser Therapie. Z Gastroenterol 2015; 53:235-43. [DOI: 10.1055/s-0034-1385711] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
| | - S. Bauer
- Innere Klinik (Tumorforschung), Universitätsklinik Essen
| | - A. Beham
- Allgemein-Viszeral- und Kinderchirurgie, Universitätsmedizin Göttingen
| | | | | | - R. Koschny
- Medizinische Klinik IV, Universität Heidelberg
| | - J. Maier
- Hämatologie und Hämostaseologie, Universität Leipzig
| | | | - D. Perez
- Allgemein-Viszeral- und Thoraxchirurgie, Universität Hamburg
| | | | | | - C. Wurst
- Allgemein- und Viszeralchirurgie, Universitätsklinikum Jena
| | - S. Cameron
- Gastroenterologie und Endokrinologie, Universitätsmedizin Göttingen
| |
Collapse
|
34
|
Grodner E, Gadea A, Sarriguren P, Lenzi SM, Grebosz J, Valiente-Dobón JJ, Algora A, Górska M, Regan PH, Rudolph D, de Angelis G, Agramunt J, Alkhomashi N, Amon Susam L, Bazzacco D, Benlliure J, Benzoni G, Boutachkov P, Bracco A, Caceres L, Cakirli RB, Crespi FCL, Domingo-Pardo C, Doncel M, Dombrádi Z, Doornenbal P, Farnea E, Ganioğlu E, Gelletly W, Gerl J, Gottardo A, Hüyük T, Kurz N, Leoni S, Mengoni D, Molina F, Morales AI, Orlandi R, Oktem Y, Page RD, Perez D, Pietri S, Podolyák Z, Poves A, Quintana B, Rinta-Antila S, Rubio B, Nara Singh BS, Steer AN, Verma S, Wadsworth R, Wieland O, Wollersheim HJ. Hindered Gamow-Teller decay to the odd-odd N=Z (62)Ga: absence of proton-neutron T=0 condensate in A=62. Phys Rev Lett 2014; 113:092501. [PMID: 25215980 DOI: 10.1103/physrevlett.113.092501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/20/2013] [Indexed: 06/03/2023]
Abstract
Search for a new kind of superfluidity built on collective proton-neutron pairs with aligned spin is performed studying the Gamow-Teller decay of the T=1, J(π)=0+ ground state of (62)Ge into excited states of the odd-odd N=Z nucleus (62)Ga. The experiment is performed at GSI Helmholtzzentrum für Shwerionenforshung with the (62)Ge ions selected by the fragment separator and implanted in a stack of Si-strip detectors, surrounded by the RISING Ge array. A half-life of T1/2=82.9(14) ms is measured for the (62)Ge ground state. Six excited states of (62)Ga, populated below 2.5 MeV through Gamow-Teller transitions, are identified. Individual Gamow-Teller transition strengths agree well with theoretical predictions of the interacting shell model and the quasiparticle random phase approximation. The absence of any sizable low-lying Gamow-Teller strength in the reported beta-decay experiment supports the hypothesis of a negligible role of coherent T=0 proton-neutron correlations in (62)Ga.
Collapse
Affiliation(s)
- E Grodner
- Faculty of Physics, University of Warsaw, Warsaw, Poland and Laboratori Nazionali di Legnaro, INFN, Legnaro, Italy
| | - A Gadea
- Laboratori Nazionali di Legnaro, INFN, Legnaro, Italy and Instituto de Física Corpuscular, CSIC-University of Valencia, Valencia, Spain
| | - P Sarriguren
- Instituto de Estructura de la Materia, CSIC, Madrid, Spain
| | - S M Lenzi
- Dipartimento di Fisica e Astronomia dell'Università di Padova, Padova, Italy and Istituto Nazionale di Fisica Nucleare, Sezione di Padova, Padova, Italy
| | - J Grebosz
- Niewodniczanski Institute of Nuclear Physics, Polish Academy of Science, Krakow, Poland
| | | | - A Algora
- Instituto de Física Corpuscular, CSIC-University of Valencia, Valencia, Spain and Institute for Nuclear Research, Hungarian Academy of Sciences, Debrecen, Hungary
| | - M Górska
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - P H Regan
- Department of Physics, University of Surrey, Guildford, United Kingdom
| | - D Rudolph
- Department of Physics, Lund University, Lund, Sweden
| | - G de Angelis
- Laboratori Nazionali di Legnaro, INFN, Legnaro, Italy
| | - J Agramunt
- Instituto de Física Corpuscular, CSIC-University of Valencia, Valencia, Spain
| | - N Alkhomashi
- Department of Physics, University of Surrey, Guildford, United Kingdom
| | - L Amon Susam
- Department of Physics, University of Istanbul, Istanbul, Turkey
| | - D Bazzacco
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, Padova, Italy
| | - J Benlliure
- Universidad de Santiago de Compostela, Santiago de Compostela, Spain
| | - G Benzoni
- Istituto Nazionale di Fisica Nucleare, Sezione di Milano, Milano, Italy
| | - P Boutachkov
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - A Bracco
- Istituto Nazionale di Fisica Nucleare, Sezione di Milano, Milano, Italy and Dipartimento di Fisica dell'Università degli Studi di Milano, Milano, Italy
| | - L Caceres
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - R B Cakirli
- Department of Physics, University of Istanbul, Istanbul, Turkey
| | - F C L Crespi
- Istituto Nazionale di Fisica Nucleare, Sezione di Milano, Milano, Italy
| | - C Domingo-Pardo
- Instituto de Física Corpuscular, CSIC-University of Valencia, Valencia, Spain and GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - M Doncel
- Laboratorio de Radiaciones Ionizantes,Universidad de Salamanca, Spain
| | - Zs Dombrádi
- Institute for Nuclear Research, Hungarian Academy of Sciences, Debrecen, Hungary
| | - P Doornenbal
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - E Farnea
- Istituto Nazionale di Fisica Nucleare, Sezione di Padova, Padova, Italy
| | - E Ganioğlu
- Department of Physics, University of Istanbul, Istanbul, Turkey
| | - W Gelletly
- Department of Physics, University of Surrey, Guildford, United Kingdom
| | - J Gerl
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - A Gottardo
- Laboratori Nazionali di Legnaro, INFN, Legnaro, Italy
| | - T Hüyük
- Instituto de Física Corpuscular, CSIC-University of Valencia, Valencia, Spain
| | - N Kurz
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - S Leoni
- Istituto Nazionale di Fisica Nucleare, Sezione di Milano, Milano, Italy and Dipartimento di Fisica dell'Università degli Studi di Milano, Milano, Italy
| | - D Mengoni
- Dipartimento di Fisica e Astronomia dell'Università di Padova, Padova, Italy and Istituto Nazionale di Fisica Nucleare, Sezione di Padova, Padova, Italy
| | - F Molina
- Instituto de Física Corpuscular, CSIC-University of Valencia, Valencia, Spain and Comisión Chilena de Energía Nuclear, P.O. Box 188-D, Santiago de Chile, Chile
| | - A I Morales
- Istituto Nazionale di Fisica Nucleare, Sezione di Milano, Milano, Italy and Dipartimento di Fisica dell'Università degli Studi di Milano, Milano, Italy
| | - R Orlandi
- Instituto de Estructura de la Materia, CSIC, Madrid, Spain
| | - Y Oktem
- Department of Physics, University of Istanbul, Istanbul, Turkey
| | - R D Page
- Department of Physics, Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - D Perez
- Universidad de Santiago de Compostela, Santiago de Compostela, Spain
| | - S Pietri
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - Zs Podolyák
- Department of Physics, University of Surrey, Guildford, United Kingdom
| | - A Poves
- Departamento de Física Teórica and IFT-UAM/CSIC, Universidad Autónoma de Madrid, Madrid, Spain
| | - B Quintana
- Laboratorio de Radiaciones Ionizantes,Universidad de Salamanca, Spain
| | - S Rinta-Antila
- Department of Physics, Oliver Lodge Laboratory, University of Liverpool, Liverpool, United Kingdom
| | - B Rubio
- Instituto de Física Corpuscular, CSIC-University of Valencia, Valencia, Spain
| | - B S Nara Singh
- Nuclear Physics Group, Department of Physics, University of York, York, United Kingdom
| | - A N Steer
- Nuclear Physics Group, Department of Physics, University of York, York, United Kingdom
| | - S Verma
- Universidad de Santiago de Compostela, Santiago de Compostela, Spain
| | - R Wadsworth
- Nuclear Physics Group, Department of Physics, University of York, York, United Kingdom
| | - O Wieland
- Istituto Nazionale di Fisica Nucleare, Sezione di Milano, Milano, Italy
| | - H J Wollersheim
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| |
Collapse
|
35
|
Mariani-Kurkdjian P, Lemaître C, Bidet P, Perez D, Boggini L, Kwon T, Bonacorsi S. Haemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype. New Microbes New Infect 2014; 2:127-31. [PMID: 25356358 PMCID: PMC4184582 DOI: 10.1002/nmi2.49] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2014] [Revised: 04/18/2014] [Accepted: 04/24/2014] [Indexed: 12/21/2022] Open
Abstract
We describe a new atypical Shiga-toxin-producing Escherichia coli (STEC) responsible for a severe episode of haemolytic–uraemic syndrome in an adult with a relapse associated with bacteraemia. This STECs train of serotype O80:H2 harboured stx2c and stx2d gene subtypes, the rare eae ξ variant and a ColV plasmid with a conserved virulence plasmidic region involved in virulence of human and avian extraintestinal pathogenic E. coli. This atypical hybrid pathotype, which represents a new threat, is a further demonstration that STEC may be a recipient for extraintestinal virulence factors and raises again the question of antibiotic therapy during STEC infection.
Collapse
Affiliation(s)
- P Mariani-Kurkdjian
- Centre National de Référence associé Escherichia coli, Hôpital Robert-Debré, AP-HP Paris, France
| | - C Lemaître
- Centre National de Référence associé Escherichia coli, Hôpital Robert-Debré, AP-HP Paris, France
| | - P Bidet
- Centre National de Référence associé Escherichia coli, Hôpital Robert-Debré, AP-HP Paris, France ; IAME, UMR 1137, INSERM Paris, France ; IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité Paris, France
| | - D Perez
- Service de Réanimation, Centre hospitalier de Lons-le-Saunier Lons-le-Saunier, France
| | - L Boggini
- Service de Microbiologie, Centre hospitalier de Lons-le-Saunier Lons-le-Saunier, France
| | - T Kwon
- Service de Néphrologie, Hôpital Robert-Debré, AP-HP Paris, France
| | - S Bonacorsi
- Centre National de Référence associé Escherichia coli, Hôpital Robert-Debré, AP-HP Paris, France ; IAME, UMR 1137, INSERM Paris, France ; IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité Paris, France
| |
Collapse
|
36
|
Contreras ML, Perez D, Rozas R. Empirical correlations between electroantennograms and bioassays forPeriplaneta americana. J Chem Ecol 2013; 15:2539-48. [PMID: 24271596 DOI: 10.1007/bf01014730] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/1988] [Accepted: 01/12/1989] [Indexed: 11/27/2022]
Abstract
Determination of electroantennograms (EAGs) with an electroantennometer having a positive and a negative peak detection option, and with a stimulus delivery device providing local stimulation of the antenna ofP. americana, allowed for the detection of three typical EAG patterns for a wide range of compounds tested. Some of the compounds presented at least one positive EAG peak (0.1-0.3 mV), others showed a single negative EAG peak (-1.0 to -1.1 mV), and a third group had more than one negative EAG peak (-0.2 to -0.8 mV). These EAG results correlate with behavioral assays ofP. americana. Thus compounds having a positive EAG response act as repellents, while those having negative EAG responses act as attractants, depending on concentration. EAG patterns thus can permit prediction of behavioral responses ofP. americana.
Collapse
Affiliation(s)
- M L Contreras
- Department of Chemistry and Biochemistry, University of Santiago, 5659, Casilla, Santiago-2, Chile
| | | | | |
Collapse
|
37
|
|
38
|
Diaz V, Gonzalez R, Salgado D, Perez D. Stroke and aphasia quality of life scale (saqol-39). Evaluation of acceptability, reliability and validity of Chilean version. J Neurol Sci 2013. [DOI: 10.1016/j.jns.2013.07.1942] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
39
|
D’Anna LH, Korosteleva OA, Perez D, O’Donnell L, Rietmeijer CA, Klausner JD, Malotte CK. P4.031 Differences in Condom Use Consistency During Vaginal and Heterosexual Anal Sex: Findings from the Safe in the City Study. Br J Vener Dis 2013. [DOI: 10.1136/sextrans-2013-051184.0929] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
40
|
Fernandez M, Calvo I, Martinez N, Herrero M, Quijano Y, Duran H, Garcia-Aranda M, Suarez A, Lopez-Rios F, Perez D, Perea S, Hidalgo M, Garcia-Estevez L. Abstract P1-14-10: Final results of neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER). Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p1-14-10] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: B in combination with T has shown meaningful activity in patients (pts) with metastatic HER2-positive breast cancer. Pathological complete response (pCR) was defined as the absence of invasive disease at the time of histological study and there is a relationship between pCR and disease-free survival (DFS) and overall survival (OS). The complete pathological response rate is between 9 to 34% of patients receiving primary treatment prior to surgery with chemotherapy and when the Herceptin was administrated, a pCR of 39% was reached.
AVANTHER is a Phase II trial of preoperative systemic therapy combining B with T and P in a weekly regimen in HER2 positive breast cancer to assess safety and efficacy of the combination.
Methods: Pts with centrally-confirmed HER2− positive (IHC 3+ or FISH positive) breast cancer (stage II or III including locally advanced) received neoadjuvant chemotherapy (NC) with weekly P (80mg/m2/week) for 12 weeks in combination with weekly T (4mg/kg loading dose and 2 mg/kg maintenance) and B (15mg/kg every 3 weeks) for 4 cycles. After surgery all pts received T (1 year) and liposomal doxorubicin plus cyclophosphamide every 3 weeks (4 cycles); primary endpoint was rate of pathological complete response (pCR) in breast and axilla. For all patients, a tissue sample at baseline as well as at surgery was collected for biomarker analyses.
Results: A total of 44 pts have been enrolled. Median tumor size: 3.9 cm. Nine (21%) pts had stage IIA; 19 (45%) stage IIB; 10 (24%) stage IIIA and 4 (10%) stage IIIB. Twenty-nine (69%) pts had estrogen positive receptors.
Data from surgery of 42 patients from a total of 44 patients enrolled were presented in this abstract, but the final results will be present in the symposium. pCR was achieved in 18 (42.9%) pts. Safety and tolerability were good, with rare adverse events of grade 3 [1 (2.4%) episode of severe hypertension, 1 (2,4%) mucosal inflammation].
We presented the results of relationship between magnetic resonance imaging (MRI) and pCR that is one of the secondary objectives of the study.
100% of the patients without pathologic response had stable disease at resonance imaging. Of all patients who had pCR only 55.6% had complete radiological response.
Conclusions: These data show that the combination of P with T and B without an anthracycline for 12 weeks is very effective as NC in HER2 positive breast cancer pts with a high rate of pCR and minimal side effects.
And the MRI is useful for identifying the persistence of residual disease however it only predicts half of the complete pathological responses
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P1-14-10.
Collapse
Affiliation(s)
- M Fernandez
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - I Calvo
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - N Martinez
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - M Herrero
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - Y Quijano
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - H Duran
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - M Garcia-Aranda
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - A Suarez
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - F Lopez-Rios
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - D Perez
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - S Perea
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - M Hidalgo
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| | - L Garcia-Estevez
- Centro Integral Oncológico Clara Campal, Madrid, Spain; Hospital Ramón y Cajal, Madrid, Spain; Hospital Costa del Sol, Marbella, Spain
| |
Collapse
|
41
|
Leland J, Perez D. Poster 63: Simultaneous Unilateral Condyle, Ramus and Mandibular Body Reconstruction With a Custom Total Joint Prosthesis System and Minimal Autogenous Bone Graft. J Oral Maxillofac Surg 2012. [DOI: 10.1016/j.joms.2012.06.119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
42
|
Abstract
The effect of thermal activation on atomic-scale friction is often described in the framework of the Prandtl-Tomlinson model. Accurate use of this model relies on parameters that describe the shape of the corrugation potential β and the transition attempt frequency f(0). We show that the commonly used form of β for a sinusoidal corrugation potential can lead to underestimation of friction, and that the attempt frequency is not, as is usually assumed, a constant value, but rather varies as the energy landscape evolves. We partially resolve these issues by demonstrating that numerical results can be captured by a model with a fitted β and using harmonic transition state theory to develop a variable form of the attempt frequency. We incorporate these developments into a more accurate and generally applicable expression relating friction to temperature and velocity. Finally, by using a master equation approach, we verify the improved analytical model is accurate in its expected regime of validity.
Collapse
Affiliation(s)
- Y Dong
- School of Mechanical Engineering, Purdue University, West Lafayette, IN 47907, USA
| | | | | | | |
Collapse
|
43
|
Walker NH, Sabanli M, Sykes PH, Russell P, Perez D. Successful reproductive outcome following treatment of advanced small cell carcinoma of the ovary. Gynecol Oncol Case Rep 2012; 2:115-7. [PMID: 24371639 DOI: 10.1016/j.gynor.2012.06.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/26/2012] [Accepted: 06/08/2012] [Indexed: 11/26/2022]
Abstract
► Ovarian small cell carcinoma usually occurs in adolescents or young adults. ► Long term survival of advanced stage disease is extremely rare. ► Fertility may be conserved and should be considered as part of management.
Collapse
Affiliation(s)
- N H Walker
- Christchurch Women's Hospital, New Zealand
| | | | | | | | - D Perez
- Dunedin Hospital, New Zealand
| |
Collapse
|
44
|
Martinez P, Marco G, Perez D, Tomas M, Prieto A, Navarro J, Rodriguez J, Baeza M, Alvarez-Perea A. Baseline Serum Tryptase Levels in Patients who Suffered Anaphylaxis. J Allergy Clin Immunol 2012. [DOI: 10.1016/j.jaci.2011.12.245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
45
|
Marco G, Rodriguez E, Nunez T, Martinez P, Pinto C, Pineda R, Perez D, Zubeldia J, Baeza M. Milk And Egg Allergy In Adulthood. J Allergy Clin Immunol 2012. [DOI: 10.1016/j.jaci.2011.12.951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Salvador J, Ciruelos E, Codes DVM, Jaen A, Gil M, Galan A, Murias A, Jara C, de LHJ, Baena JM, Villanueva MJ, Bayo J, Blancas I, Gonzalez E, Perez D, Mel JR, Manso L. P1-14-03: AVALUZ Study: First Line with Bevacizumab in Combination with Paclitaxel (P) and Gemcitabine (G) in Patients with HER-2 Negative Recurrent or Metastatic BC: PFS Analysis. Cancer Res 2011. [DOI: 10.1158/0008-5472.sabcs11-p1-14-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background The combination of bevacizumab (B) with taxanes, capecitabine or anthracyclines has shown increased PFS in pts with mBC. The combination with G and P has been evaluated and has demonstrated high response rate and good toxicity profile. The aim of this study is to evaluate the efficacy and toxicity profile of the combination of B with G and P, providing an update of PFS and the toxicity experienced in all patients treated.
Methods A phase II multicenter, national, open-label study in pts diagnosed of recurrent or metastatic HER-2 negative BC, treated with first line B 10 mg/kg, P 150 mg/m2 and G 2000 mg/m2 day 1 and 15 c/28 d until progression disease, unacceptable toxicity or medical decision. This abstract evaluates efficacy by PFS as primary endpoint and as secondary endpoints: response rate and toxicity profile (NCI CTC v3.0 criteria).
Results From January 2009 to December 2009, 82 evaluable patients were recruited in 23 sites. The characteristic of the all of patients included (90) are: median age 51.5 (26-81), ER + 68%, PR + 59%, triple negative pts 19%, previous chemotherapy (neoadj or adj) 64.4% and ≥ 3 metastatic sites 21% of patients (19). The median cycles administered per pts was 7 (1-26) and the relative median dose intensity was 0.93 for B, 0.89 for P and 0.91 for G.
Of the 75 patients with response assessment, the overall response rate obtained was 72% with a clinical benefit of 89.3% (80.6−95.28%) (CR 14.7% (11), PR 57.3% (43), SD 17.3% and PD 10.7%). Of the 82 patients with a median follow up of 16.5 m (0.16- 26.38), preliminary median PFS (43% events) for these pts was 11.48 m (8.98−15.72), the median duration of first response (MDR) was 12.4 m (7.47-NA) and the median OS was 21.35 m (20.72- NA). The one year OS% was 84.15% (74.27 - 90.47).
Toxicity was generally manageable. Related AEs have been reported in 67/82 patients which were mostly mild or moderate. Safety analysis revealed 24 SAEs in 21 patients.
Conclusions Bevacizumab in combination with paclitaxel and gemcitabine showed significant PFS compared with the published data with paclitaxel and gemcitabine and high clinical benefit with manageable safety profile.
Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P1-14-03.
Collapse
Affiliation(s)
- J Salvador
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - E Ciruelos
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - de Villena M Codes
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - A Jaen
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - M Gil
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - A Galan
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - A Murias
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - C Jara
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - la Haba J de
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - JM Baena
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - MJ Villanueva
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - J Bayo
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - I Blancas
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - E Gonzalez
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - D Perez
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - JR Mel
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| | - L Manso
- 1Hospital U. de Valme, Sevilla, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen Macarena, Sevilla, Spain; Hospital de Jaen, Jaen, Spain; ICO, Bellvitge, Spain; Hospital de Sagunto, Sagunto, Spain; Hospital Insular de Gran Canaria, Gran Canaria, Spain; Fundacion Hospital de Alcorcon, Alcorcon, Spain; Hospital Reina Sofia, Cordoba, Spain; Hospital Puerta del Mar, Cadiz, Spain; Hospital Meixoeiro, Vigo, Spain; Hospital Juan Ramón Jimenez, Huelva, Spain; Hospital San Cecilio, Granada, Spain; Hospital Virgen de las Nieves, Granada, Spain; Hospital Costa del Sol, Marbella, Spain; Hospital Lucus Augusti, Lugo, Spain
| |
Collapse
|
47
|
Manso L, Ciruelos E, Codes M, De la Haba J, Galan A, Baena J, Jaen A, Gil M, Murias A, Blancas I, Gonzalez E, Perez D, Bayo JL, Mel J, Garcia-Martinez E, Cubedo R, Salvador J. Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy. Breast Cancer Res 2011. [PMCID: PMC3247052 DOI: 10.1186/bcr3025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
48
|
Beltran-Salinas B, Cervantes A, Martinez H, Perez D. Temporomandibular joint ankylosis: reconstruction with costochondral graft. Follow-up of two cases. Int J Oral Maxillofac Surg 2011. [DOI: 10.1016/j.ijom.2011.07.619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
49
|
Beltran B, Villalpando C, Perez D, Favela J. Reconstruction of orbital wall defects: with alternative biomaterials. Int J Oral Maxillofac Surg 2011. [DOI: 10.1016/j.ijom.2011.07.1028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
50
|
Cervantes A, Beltran B, Perez D, Villarreal A. Orthognatic surgery: anterior segmental osteotomy. Int J Oral Maxillofac Surg 2011. [DOI: 10.1016/j.ijom.2011.07.595] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|